Risk factors for herpes simplex virus transmission to pregnant women: A couples study

被引:10
作者
Baker, DA [1 ]
机构
[1] SUNY Stony Brook, Hlth Sci Ctr, Div Infect Dis, Dept Obstet Gynecol & Reprod Med, Stony Brook, NY 11794 USA
关键词
D O I
10.1016/j.ajog.2005.08.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study was undertaken to determine risk factors for herpes simplex virus (HSV) acquisition among at risk pregnant women. Study design: Women in a prospective study of HSV acquisition in pregnancy invited their sexual partners for HSV type-specific serologic testing. Risk factors for HSV susceptibility, exposure, and acquisition were examined. Results: A total of 3192 couples enrolled; 22% included women at risk for HSV-1 or HSV-2. Among 582 HSV-1 seronegative women with HSV-1 seropositive partners, 14 (3.5% adjusted for gestation length) acquired HSV-1. Having a partner with a history of oral herpes was associated with HSV-1 acquisition (odds ratio [OR] 8.1, 95% CI: 1.8-36.0) and accounted for 75% of incident infections. Among 125 HSV-2 seronegative women with HSV-2 seropositive partners, 17 (20% adjusted for gestation length) acquired HSV-2. Duration of partnership of 1 year or less was associated with HSV-2 acquisition (OR 7.8, 95% CI: 2.3-25.7) and accounted for 63% of incident infections. No combination of clinical characteristics could identify the majority of susceptible women with serologically discordant partners. Conclusion: HSV acquisition rates in pregnancy are high in discordant couples, especially for HSV-2. Interventions that address risk factors for HSV acquisition should be studied in pregnancy. Clinical profiles cannot replace serologic screening to identify susceptible women with serologically discordant partners. © 2005 Mosby, Inc. All rights reserved.
引用
收藏
页码:1887 / 1888
页数:2
相关论文
共 8 条
[1]   Cost-effectiveness of herpes simplex virus type 2 serotogic testing and antiviral therapy in pregnancy [J].
Baker, D ;
Brown, Z ;
Hollier, LM ;
Wendel, GD ;
Hulme, L ;
Griffiths, DA ;
Mauskopf, J .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (06) :2074-2084
[2]   Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from-mother to infant [J].
Brown, ZA ;
Wald, A ;
Morrow, RA ;
Selke, S ;
Zeh, J ;
Corey, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (02) :203-209
[3]   Once-daily valacyclovir to reduce the risk of transmission of genital herpes [J].
Corey, L ;
Wald, A ;
Patel, R ;
Sacks, SL ;
Tyring, SK ;
Warren, T ;
Douglas, JM ;
Paavonen, J ;
Morrow, RA ;
Beutner, KR ;
Stratchounsky, LS ;
Mertz, G ;
Keene, ON ;
Watson, HA ;
Tait, D ;
Vargas-Cortes, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :11-20
[4]   Herpes simplex virus type 2 in the United States, 1976 TO 1994 [J].
Fleming, DT ;
McQuillan, GM ;
Johnson, RE ;
Nahmias, AJ ;
Aral, SO ;
Lee, FK ;
StLouis, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (16) :1105-1111
[5]  
SHEFFIELD JS, 2005, ANN CLIN M AM COLL O
[6]  
2002, MMWR MORB MORTAL WKL, V51, P12
[7]  
1909, AM COLL OBSTET GYNEC, V8
[8]  
2002, GUIDELINES PERINATAL, P292